Low-Dose IL-2 Therapy in Transplantation, Autoimmunity, and Inflammatory Diseases
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Low-Dose IL-2 Therapy in Transplantation, Autoimmunity, and Inflammatory Diseases
Authors
Keywords
-
Journal
JOURNAL OF IMMUNOLOGY
Volume 203, Issue 11, Pages 2749-2755
Publisher
The American Association of Immunologists
Online
2019-11-19
DOI
10.4049/jimmunol.1900733
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systemic IL-2/anti-IL-2Ab complex combined with sublingual immunotherapy suppresses experimental food allergy in mice through induction of mucosal regulatory T cells
- (2018) P. L. Smaldini et al. ALLERGY
- Interleukin 2 promotes hepatic regulatory T cell responses and protects from biliary fibrosis in murine sclerosing cholangitis
- (2018) Amy E. Taylor et al. HEPATOLOGY
- A human anti-IL-2 antibody that potentiates regulatory T cells by a structure-based mechanism
- (2018) Eleonora Trotta et al. NATURE MEDICINE
- Low-dose IL-2 expands CD4+ regulatory T cells with a suppressive function in vitro via the STAT5-dependent pathway in patients with chronic kidney diseases
- (2018) Yuanyuan Li et al. RENAL FAILURE
- Treatment of T1D via optimized expansion of antigen-specific Tregs induced by IL-2/anti-IL-2 monoclonal antibody complexes and peptide/MHC tetramers
- (2018) Cristina Izquierdo et al. Scientific Reports
- IL-2–Anti–IL-2 Monoclonal Antibody Immune Complexes Inhibit Collagen-Induced Arthritis by Augmenting Regulatory T Cell Functions
- (2018) Yuichi Yokoyama et al. JOURNAL OF IMMUNOLOGY
- A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease
- (2018) Laurence B. Peterson et al. JOURNAL OF AUTOIMMUNITY
- In Vivo Expansion of Regulatory T Cells with IL-2/IL-2 Antibody Complex Protects against Transient Ischemic Stroke
- (2018) Haiyue Zhang et al. JOURNAL OF NEUROSCIENCE
- Preventing murine transfusion-related acute lung injury by expansion of CD4+ CD25+ FoxP3+ Tregs using IL-2/anti-IL-2 complexes
- (2018) Rui He et al. TRANSFUSION
- IL-2 promotes early Treg reconstitution after allogeneic hematopoietic cell transplantation
- (2017) Brian C. Betts et al. HAEMATOLOGICA
- Low-dose interleukin-2 as a modulator of Treg homeostasis after HSCT: current understanding and future perspectives
- (2017) Ken-ichi Matsuoka INTERNATIONAL JOURNAL OF HEMATOLOGY
- IL-2/anti-IL-2 complexes ameliorate lupus nephritis by expansion of CD4+CD25+Foxp3+ regulatory T cells
- (2017) Ji-Jing Yan et al. KIDNEY INTERNATIONAL
- IL-2 therapy restores regulatory T-cell dysfunction induced by calcineurin inhibitors
- (2017) Gavin Whitehouse et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IL-2 promotes early Treg reconstitution after allogeneic hematopoietic cell transplantation
- (2017) Brian C. Betts et al. HAEMATOLOGICA
- Promoting Immune Regulation in Type 1 Diabetes Using Low-Dose Interleukin-2
- (2016) Connor J. Dwyer et al. Current Diabetes Reports
- Restoring regulation – IL-2 therapy in systemic lupus erythematosus
- (2016) Jens Y. Humrich et al. Expert Review of Clinical Immunology
- Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus
- (2016) Jing He et al. NATURE MEDICINE
- In Vivo Expansion of Regulatory T Cells by Low-Dose Interleukin-2 Treatment Increases Allograft Survival in Corneal Transplantation
- (2016) Maryam Tahvildari et al. TRANSPLANTATION
- Prophylactic use of low-dose interleukin-2 and the clinical outcomes of hematopoietic stem cell transplantation: A randomized study
- (2016) Xiang-Yu Zhao et al. OncoImmunology
- Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus
- (2015) Caroline von Spee-Mayer et al. ANNALS OF THE RHEUMATIC DISEASES
- Rapid induction of clinical remission by low-dose interleukin-2 in a patient with refractory SLE
- (2015) Jens Y Humrich et al. ANNALS OF THE RHEUMATIC DISEASES
- Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients
- (2015) Michelle Rosenzwajg et al. JOURNAL OF AUTOIMMUNITY
- Administration of Low Doses of IL-2 Combined to Rapamycin Promotes Allogeneic Skin Graft Survival in Mice
- (2014) C. B. Pilon et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Interleukin 2 in the Pathogenesis and Therapy of Type 1 Diabetes
- (2014) Michelle Rosenzwajg et al. Current Diabetes Reports
- Suppression of Murine Allergic Airway Disease by IL-2:Anti-IL-2 Monoclonal Antibody-Induced Regulatory T Cells
- (2014) M. S. Wilson et al. JOURNAL OF IMMUNOLOGY
- Effects of Low-Dose Recombinant Interleukin 2 to Promote T-Regulatory Cells in Alopecia Areata
- (2014) Emeline Castela et al. JAMA Dermatology
- The life of regulatory T cells
- (2013) Iris K. Gratz et al. Annals of the New York Academy of Sciences
- IL-2/Anti-IL-2 Complex Attenuates Renal Ischemia-Reperfusion Injury through Expansion of Regulatory T Cells
- (2013) M.-G. Kim et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease
- (2013) K.-i. Matsuoka et al. Science Translational Medicine
- Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial
- (2013) Agnès Hartemann et al. Lancet Diabetes & Endocrinology
- CTLA4-Ig Restores Rejection of MHC Class-II Mismatched Allografts by Disabling IL-2-Expanded Regulatory T Cells
- (2012) L.-M. Charbonnier et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Impact of Interleukin-2–expanded Regulatory T Cells in Various Allogeneic Combinations on Mouse Skin Graft Survival
- (2012) B. Vokaer et al. TRANSPLANTATION PROCEEDINGS
- Effect of Rapamycin and Interleukin-2 on Regulatory CD4+CD25+Foxp3+ T Cells in Mice After Allogenic Corneal Transplantation
- (2012) X. Wang et al. TRANSPLANTATION PROCEEDINGS
- Regulatory T-Cell Responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis
- (2011) David Saadoun et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
- (2011) John Koreth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regulatory T Cells: Customizing for the Clinic
- (2011) X. Wang et al. Science Translational Medicine
- CD4+Foxp3+ regulatory T cell therapy in transplantation
- (2011) Q. Tang et al. Journal of Molecular Cell Biology
- NFAT pulls the strings during CD4+ T helper cell effector functions
- (2010) N. Hermann-Kleiter et al. BLOOD
- In vivo expansion of T reg cells with IL-2–mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression
- (2009) Kylie E. Webster et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Genetics of Type 1A Diabetes
- (2009) Patrick Concannon et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started